A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003)

Double Blind Placebo ◽

Withdrawal Design ◽

An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain

Pain ◽

10.1016/j.pain.2012.06.024 ◽

2012 ◽

Vol 153 (10) ◽

pp. 2073-2082 ◽

Cited By ~ 80

Author(s):

Cory Toth ◽

Shefina Mawani ◽

Shauna Brady ◽

Cynthia Chan ◽

CaiXia Liu ◽

...

Keyword(s):

Neuropathic Pain ◽

Efficacy Study ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955170.793461800 ◽

2012 ◽

Author(s):

John Kamholz

Keyword(s):

Neuropathic Pain ◽

Efficacy Study ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy of Pregabalin for Peripheral Neuropathic Pain: Results of an 8-Week, Flexible-Dose, Double-Blind, Placebo-Controlled Study Conducted in China

Clinical Therapeutics ◽

10.1016/j.clinthera.2011.02.007 ◽

2011 ◽

Vol 33 (2) ◽

pp. 159-166 ◽

Cited By ~ 35

Author(s):

Yuzhou Guan ◽

Xinsheng Ding ◽

Yan Cheng ◽

Dongsheng Fan ◽

Lan Tan ◽

...

Keyword(s):

Neuropathic Pain ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1104054.560029 ◽

2008 ◽

Author(s):

Stephen Tyrer

Keyword(s):

Neuropathic Pain ◽

Evidence Based ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Parallel Group ◽

Post Hoc

Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evidence-Based Findings from Post Hoc Analysis of Three Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Studies

Clinical Therapeutics ◽

10.1016/j.clinthera.2007.12.002 ◽

2007 ◽

Vol 29 (11) ◽

pp. 2536-2546 ◽

Cited By ~ 92

Author(s):

Daniel K. Kajdasz ◽

Smriti Iyengar ◽

Durisala Desaiah ◽

Misha-Miroslav Backonja ◽

John T. Farrar ◽

...

Keyword(s):

Neuropathic Pain ◽

Evidence Based ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Parallel Group ◽

Post Hoc

A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain

Pain ◽

10.1097/j.pain.0000000000000263 ◽

2015 ◽

Vol 156 (10) ◽

pp. 2013-2020 ◽

Cited By ~ 44

Author(s):

Dan Ziegler ◽

W. Rachel Duan ◽

Guohua An ◽

James W. Thomas ◽

Wolfram Nothaft

Keyword(s):

Neuropathic Pain ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Controlled Study ◽

Double Blind ◽

Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double‐blind, placebo‐controlled phase III study in Asian patients

Journal of Diabetes Investigation ◽

10.1111/jdi.13013 ◽

2019 ◽

Vol 10 (5) ◽

pp. 1299-1306 ◽

Cited By ~ 13

Author(s):

Masayuki Baba ◽

Norimitsu Matsui ◽

Masanori Kuroha ◽

Yosuke Wasaki ◽

Shoichi Ohwada

Keyword(s):

Neuropathic Pain ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Asian Patients ◽

Phase Iii Study

The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials

Expert Opinion on Drug Safety ◽

10.1080/14740338.2020.1764934 ◽

2020 ◽

Vol 19 (6) ◽

pp. 707-733 ◽

Cited By ~ 3

Author(s):

Marie Selvy ◽

Mélissa Cuménal ◽

Nicolas Kerckhove ◽

Christine Courteix ◽

Jérôme Busserolles ◽

...

Keyword(s):

Clinical Trials ◽

Neuropathic Pain ◽

Randomized Clinical Trials ◽

Double Blind ◽

The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study

Pain ◽

10.1016/j.pain.2014.08.014 ◽

2014 ◽

Vol 155 (11) ◽

pp. 2263-2273 ◽

Cited By ~ 235

Author(s):

Dyveke T. Demant ◽

Karen Lund ◽

Jan Vollert ◽

Christoph Maier ◽

Märtha Segerdahl ◽

...

Keyword(s):

Neuropathic Pain ◽

Double Blind ◽

Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(16)00017-x ◽

2016 ◽

Vol 15 (6) ◽

pp. 555-565 ◽

Cited By ~ 101

Author(s):

Nadine Attal ◽

Daniel C de Andrade ◽

Frédéric Adam ◽

Danièle Ranoux ◽

Manoel J Teixeira ◽

...

Keyword(s):

Neuropathic Pain ◽

Botulinum Toxin ◽

Botulinum Toxin A ◽

Controlled Trial ◽

Toxin A ◽

Double Blind ◽

Safety And Efficacy ◽